Provided by Tiger Trade Technology Pte. Ltd.

INCANNEX HEALTHCARE LTD

3.26
+0.01000.31%
Post-market: 3.25-0.0100-0.31%19:30 EDT
Volume:59.00K
Turnover:193.03K
Market Cap:39.00M
PE:-0.20
High:3.32
Open:3.25
Low:3.20
Close:3.25
52wk High:20.31
52wk Low:2.49
Shares:11.96M
Float Shares:10.50M
Volume Ratio:1.13
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-16.6200
EPS(LYR):-40.8237
ROE:-117.17%
ROA:-32.19%
PB:0.52
PE(LYR):-0.08

Loading ...

Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position

THOMSON REUTERS
·
Sep 09

Incannex Wins US Patent for IHL-42X Obstructive Sleep Apnea Treatment, Expiry 2040

Reuters
·
Sep 09

Incannex doses first patient in DReAMzz study of IHL-42X

TIPRANKS
·
Aug 25

Incannex Announces First Patient Dosed in Dreamzz Phase 2 Study of Ihl-42X

THOMSON REUTERS
·
Aug 25

Incannex Doses First Patient in Phase 2 DReAMzz Trial of IHL-42X for Sleep Apnea

Reuters
·
Aug 25

Incannex Receives Additional A$5.1 Million Research and Development Tax Incentive Refund

Reuters
·
Aug 11

Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More than A$11.2 Million in Non-Dilutive Capital Received in 2026

THOMSON REUTERS
·
Aug 11

Incannex Wins Approval of Overseas Findings, Secures A$5.1 Million R&D Tax Refund

Reuters
·
Aug 11

Incannex Healthcare - Receives Final A$5.1 Mln R&D Tax Incentive Refund for FY25 - SEC Filing

THOMSON REUTERS
·
Aug 11

Incannex Commences Participant Screening in Dreamzz Phase 2 Study of Ihl-42x for Obstructive Sleep Apnea

THOMSON REUTERS
·
Jul 23

Incannex Healthcare Announces Press Release Availability

Reuters
·
Jul 23

Incannex Starts Screening Patients in Phase 2 Dreamzz Trial of Ihl-42x for Sleep Apnea

Reuters
·
Jul 23

Incannex granted IHL-42X composition patent by USPTO

TIPRANKS
·
Jun 25

Incannex Healthcare - Granted U.S. Patent for Ihl-42x in Obstructive Sleep Apnoea - SEC Filing

THOMSON REUTERS
·
Jun 25

Incannex Wins US Patent for Ihl-42x Obstructive Sleep Apnea Therapy

Reuters
·
Jun 25

Press Release: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility

Dow Jones
·
Jun 10

Incannex Healthcare - Receives a$6 Mln R&D Tax Incentive Refund for FY25 - SEC Filing

THOMSON REUTERS
·
Jun 10

Incannex Healthcare Inc: Expects Additional a$5.1 Mln in R&D Tax Incentive Proceeds in 2026

THOMSON REUTERS
·
Jun 10

Incannex Healthcare receives A$6.04 million Australia R&D tax incentive refund

Reuters
·
Jun 10

Alliance Global Partners initiates Incannex coverage with Buy rating, US$18 price target

Reuters
·
Jun 09